Matches in Wikidata for { <http://www.wikidata.org/entity/Q79631774> ?p ?o ?g. }
Showing items 1 to 50 of
50
with 100 items per page.
- Q79631774 description "artikull shkencor i botuar më 01 shkurt 2007" @default.
- Q79631774 description "artículu científicu espublizáu en febreru de 2007" @default.
- Q79631774 description "im Februar 2007 veröffentlichter wissenschaftlicher Artikel" @default.
- Q79631774 description "scientific article published on 01 February 2007" @default.
- Q79631774 description "wetenschappelijk artikel" @default.
- Q79631774 description "наукова стаття, опублікована в лютому 2007" @default.
- Q79631774 name "Pharmacokinetics, safety, and tolerability of the oral Renin inhibitor aliskiren in patients with hepatic impairment" @default.
- Q79631774 name "Pharmacokinetics, safety, and tolerability of the oral Renin inhibitor aliskiren in patients with hepatic impairment" @default.
- Q79631774 name "Pharmacokinetics, safety, and tolerability of the oral Renin inhibitor aliskiren in patients with hepatic impairment" @default.
- Q79631774 type Item @default.
- Q79631774 label "Pharmacokinetics, safety, and tolerability of the oral Renin inhibitor aliskiren in patients with hepatic impairment" @default.
- Q79631774 label "Pharmacokinetics, safety, and tolerability of the oral Renin inhibitor aliskiren in patients with hepatic impairment" @default.
- Q79631774 label "Pharmacokinetics, safety, and tolerability of the oral Renin inhibitor aliskiren in patients with hepatic impairment" @default.
- Q79631774 prefLabel "Pharmacokinetics, safety, and tolerability of the oral Renin inhibitor aliskiren in patients with hepatic impairment" @default.
- Q79631774 prefLabel "Pharmacokinetics, safety, and tolerability of the oral Renin inhibitor aliskiren in patients with hepatic impairment" @default.
- Q79631774 prefLabel "Pharmacokinetics, safety, and tolerability of the oral Renin inhibitor aliskiren in patients with hepatic impairment" @default.
- Q79631774 P1433 Q79631774-EB0BBDB3-DB05-429E-95A8-15115D28612B @default.
- Q79631774 P1476 Q79631774-45369FCA-C3D6-48AB-8E6A-1525A8A6F9D3 @default.
- Q79631774 P2093 Q79631774-1184449F-3066-4A63-A8B6-C092E7CD65A6 @default.
- Q79631774 P2093 Q79631774-45162A8E-C3BE-45C1-B925-09CF62B43AF6 @default.
- Q79631774 P2093 Q79631774-630E6CF2-B359-44F1-AB46-C1C6C6B0C0EF @default.
- Q79631774 P2093 Q79631774-79E95DAD-6BFE-46AC-96BC-D08180522B13 @default.
- Q79631774 P2093 Q79631774-DAE5D5F4-2932-4304-AF62-2BC92EE80303 @default.
- Q79631774 P2093 Q79631774-FD4E6AA3-40A5-4F0E-BBBF-A3D07E584776 @default.
- Q79631774 P304 Q79631774-22D3B711-346A-4925-8025-6D8C0D9C299F @default.
- Q79631774 P31 Q79631774-6D89A12A-0F10-48FB-B3F7-1E1D9A4A0DCE @default.
- Q79631774 P356 Q79631774-925B5C9D-6052-4011-AB09-363F077D3F94 @default.
- Q79631774 P433 Q79631774-7D0AC002-CDC6-442C-B931-774AFEE06D94 @default.
- Q79631774 P478 Q79631774-E26277BA-FB7A-4108-9897-C3DA35E76EC7 @default.
- Q79631774 P577 Q79631774-71BE35E9-BFDC-4DE1-A686-3144F5F40C99 @default.
- Q79631774 P698 Q79631774-E2469DD9-289D-4D71-827F-A0605DC13028 @default.
- Q79631774 P921 Q79631774-FE8D704F-F1D7-420B-90E7-1A86EA0116DA @default.
- Q79631774 P356 0091270006294404 @default.
- Q79631774 P698 17244770 @default.
- Q79631774 P1433 Q7743562 @default.
- Q79631774 P1476 "Pharmacokinetics, safety, and tolerability of the oral Renin inhibitor aliskiren in patients with hepatic impairment" @default.
- Q79631774 P2093 "Chingming Yeh" @default.
- Q79631774 P2093 "Hans Armin Dieterich" @default.
- Q79631774 P2093 "Marie-Noelle Bizot" @default.
- Q79631774 P2093 "Sujata Vaidyanathan" @default.
- Q79631774 P2093 "Vance Warren" @default.
- Q79631774 P2093 "William P Dole" @default.
- Q79631774 P304 "192-200" @default.
- Q79631774 P31 Q13442814 @default.
- Q79631774 P356 "10.1177/0091270006294404" @default.
- Q79631774 P433 "2" @default.
- Q79631774 P478 "47" @default.
- Q79631774 P577 "2007-02-01T00:00:00Z" @default.
- Q79631774 P698 "17244770" @default.
- Q79631774 P921 Q323936 @default.